Cargando…
P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES
Autores principales: | Taghi Khani, A., Kumar, A., Radecki, K., Lee, S. J., Sanchez Ortiz, A., Lorenson, M., Wu, X., Koff, J., Forman, S., Gu, Z., Walker, A., Swaminathan, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429344/ http://dx.doi.org/10.1097/01.HS9.0000848048.13001.58 |
Ejemplares similares
-
Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms
por: Taghi Khani, Adeleh, et al.
Publicado: (2023) -
Prolactin Receptor (PRLR) Isoform Expression in the Murine Oviduct
por: Radecki, Kelly C, et al.
Publicado: (2021) -
Multiple cell types in the oviduct express the prolactin receptor
por: Radecki, Kelly C., et al.
Publicado: (2022) -
Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2021) -
Disturbed B-lymphocytes selection in autoimmune lymphoproliferative syndrome
por: Janda, Aleš, et al.
Publicado: (2015)